Innova Captab Intrinsic Value

INNOVACAP • Healthcare
Current Stock Price
₹733.20
Primary Intrinsic Value
₹455.84
Market Cap
₹4179 Cr
-54.1% Downside
Median Value
₹336.49
Value Range
₹220 - ₹540
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

INNOVACAP Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹455.84 ₹364.67 - ₹547.01 -37.8% EPS: ₹20.72, Sector P/E: 22x
Book Value Method asset ₹336.49 ₹302.84 - ₹370.14 -54.1% Book Value/Share: ₹168.25, P/B: 2.0x
Revenue Multiple Method revenue ₹540.35 ₹486.32 - ₹594.39 -26.3% Revenue/Share: ₹270.18, P/S: 2.0x
EBITDA Multiple Method earnings ₹383.58 ₹345.22 - ₹421.94 -47.7% EBITDA: ₹224.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹293.28 ₹234.62 - ₹351.94 -60.0% CF Growth: 11.1%, Discount: 15%
PEG Ratio Method growth ₹219.96 ₹197.96 - ₹241.96 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹320.12 ₹288.11 - ₹352.13 -56.3% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹366.60 ₹329.94 - ₹403.26 -50.0% ROE: 12.5%, P/E Multiple: 12x
Graham Defensive Method conservative ₹280.06 ₹252.05 - ₹308.07 -61.8% EPS: ₹20.72, BVPS: ₹168.25
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check INNOVACAP share price latest .

Valuation Comparison Chart

INNOVACAP Intrinsic Value Analysis

What is the intrinsic value of INNOVACAP?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Innova Captab (INNOVACAP) is ₹336.49 (median value). With the current market price of ₹733.20, this represents a -54.1% variance from our estimated fair value.

The valuation range spans from ₹219.96 to ₹540.35, indicating ₹219.96 - ₹540.35.

Is INNOVACAP undervalued or overvalued?

Based on our multi-method analysis, Innova Captab (INNOVACAP) appears to be trading above calculated value by approximately 54.1%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 2.60 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.65 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 12.5% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 14.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.97x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹64 Cr ₹-12 Cr Positive Operating Cash Flow 6/10
March 2024 ₹146 Cr ₹-104 Cr Positive Operating Cash Flow 6/10
March 2023 ₹67 Cr ₹22 Cr Positive Free Cash Flow 7/10
March 2022 ₹59 Cr ₹-35 Cr Positive Operating Cash Flow 6/10
March 2021 ₹42 Cr ₹32 Cr Positive Free Cash Flow 8/10